Fig. 2From: Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinASubjects with improvement or worsening of EQ-5D ratings in all dimensions (FAS). Time points: from study baseline to the end of injection cycle 3 (N = 138). EQ-5D, EuroQol 5-dimensions questionnaire, three-level; FAS, full analysis set; n, number of observed casesBack to article page